Hop (Humulus lupulus L.) extract inhibits obesity in mice fed a high-fat diet over the long term

British Journal of Nutrition

Volumn 109, Issue 1, 2013, Pages 162-172

  Sumiyoshi, Maho ^a   Kimura, Yoshiyuki ^a  

^a EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Anti obesity effects; Glucose tolerance; High fat diet; Hops (Humulus lupulus L.); PPAR

Indexed keywords

CHOLESTEROL; FATTY ACID; GLUCOSE; HUMULUS LUPULUS EXTRACT; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; TRIACYLGLYCEROL; TRIACYLGLYCEROL LIPASE;

ADIPOCYTE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOBESITY ACTIVITY; ARTICLE; BODY WEIGHT; CALORIC INTAKE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SIZE; CELL STRAIN 3T3; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; ENZYME ACTIVITY; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; IN VITRO STUDY; LIPID BLOOD LEVEL; LIPID DIET; LIPID LIVER LEVEL; LIPID STORAGE; MALE; MOUSE; NONHUMAN; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PROTEIN EXPRESSION;

3T3-L1 CELLS; ADIPOCYTES, WHITE; ADIPOSITY; ANIMALS; ANTI-OBESITY AGENTS; CELL SIZE; DIET, HIGH-FAT; DIETARY SUPPLEMENTS; FATTY LIVER; FLOWERING TOPS; GLUCOSE INTOLERANCE; HUMULUS; LIPID METABOLISM; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; OBESITY; PHYTOTHERAPY; PLANT EXTRACTS; PPAR GAMMA; WATER-ELECTROLYTE IMBALANCE;

HUMULUS; HUMULUS LUPULUS; MUS;

EID: 84872037445     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S000711451200061X     Document Type: Article

References (43)

1. Kurasawa T, Chikaraishi Y, Naito A, et al. (2005) Effect of Humulus lupulus on gastric secretion in a rat pylorus-ligated model. Biol Pharm Bull 28, 353-357.
2. Heyerick A, Vervarcke S, Depypere H, et al. (2006) A first prospective, randomized, double-blind, placebo-controlled study on the use of a standardized hop extract to alleviate menopausal discomforts. Maturitas 54, 164-175.
3. Yamaguchi N, Satoh-Yamaguchi K & Ono M (2009) In vitro evaluation of antibacterial, anticollagenase, and antioxidant activities of hop components (Humulus lupulus) addressing acne vulgaris. Phytomedicine 16, 369-376.
4. Shimamura M, Hazato T, Ashino H, et al. (2001) Inhibition of angiogenesis by humulone, a bitter acid from beer hop. Biochem Biophys Res Commun 289, 220-224.
5. Yasukawa K, Takeuchi M & Takido M (1995) Humulone, a bitter in the hop, inhibits tumor promotion by 12-O-tetradecanoylphorbol-13-acetate in two-stage carcinogenesis in mouse skin. Oncology 52, 156-158.
6. Yamamoto K, Wang J, Yamamoto S, et al. (2000) Suppression of cylooxygenase-2 gene transcription by humulone of beer hop extract studies with reference to glucocorticoid. FEBS Lett 465, 103-106.
7. Lee JC, Kundu JK, Hwang DM, et al. (2007) Humulone inhibits phorbol ester-induced COX-2 expression in mouse skin by blocking activation of NF-kB and AP-1: IkB kinase and c-Jun-N-terminal kinase as respective potential upstream targets. Carcinogenesis 28, 1491-1498.
8. Nozawa N (2005) Xanthohumol, the chalcone from beer hops (Humulus lupulus L.), is the ligand for farnesoid X receptor and ameliorates lipid and glucose metabolism in KK-Ay mice. Biochem Biophys Res Commun 336, 754-761.
9. Colgate EC, Miranda CL, Stevens JF, et al. (2007) Xanthohumol, a prenylflavonoid derived from hops induces apoptosis and inhibits NF-kappaB activation in prostate epithelial cells. Cancer Lett 246, 201-209.
10. Mendes V, Monterio R, Pestana D, et al. (2008) Xanthohumol influences preadipocyte differentiation: implication of antiproliferative and apoptotic effects. J Agric Food Chem 56, 11631-11637.
11. Yajima H, Ikeshima E, Shiraki M, et al. (2004) Isohumulones, bitter acids derived from hops, activate both peroxisome proliferators-activated receptor a and g and reduce insulin resistance. J Biol Chem 279, 33456-33462.
12. Yajima H, Noguchi T, Ikeshima E, et al. (2005) Prevention of diet-induced obesity by dietary isomerized hop extract containing isohumulones, in rodents. Int J Obes 29, 991-997.
13. Miura Y, Hosono M, Oyamada C, et al. (2005) Dietary isohumulones, the bitter components of beer, raise plasma HDL-cholesterol levels and reduce liver cholesterol and triacylglycerol contents similar to PPARa activation in C57BL/6 mice. Br J Nutr 93, 559-567.
14. Shimura M, Hasumi A, Minato T, et al. (2005) Isohumulones modulate blood lipid status through the activation of PPARa. Biochim Biopys Acta 1736, 51-60.
15. Obara K, Mizutani M, Hitomi Y, et al. (2009) Isohumulones, the bitter component of beer, improve hyperglycemia and decrease body fat in Japanese subjects with prediabetes. Clin Nutr 28, 278-284.
16. Namikoshi T, Tomita N, Fujimoto S, et al. (2007) Isohumulones derived from hops ameliorate renal injury via an anti-oxidative effect in Dahl salt-sensitive rats. Hypertens Res 30, 175-184.
17. Fletcher MJ (1968) A colorimetric method for estimating serum triglycerides. Clin Chem Acta 22, 393-397.
18. Zak B, Dickman RC, White EG, et al. (1954) Rapid estimation of free and total cholesterol. Am J Clin Pathol 24, 1307-1315.
19. Han L-K, Takaku T, Li J, et al. (1999) Anti-obesity action of oolong tea. Int J Obesity 23, 98-105.
20. Hagino K, Oshige H, Ozawa K, et al. (1991) Effect of XKJ-001, a crude drug preparation, on body water distribution and water excretion in mice. Yakugaku Zasshi 111, 293-298 (In Japanese).
21. Novikoff AB, Novikoff PM, Rosen OM, et al. (1980) Organelle relationships in cultured 3T3-L1 preadipocytes. J Cell Biol 87, 180-196.
22. Flatt JP (1987) The difference in the storage capacities for carbohydrate and for fat, and its implications in the regulation of body weight. Ann N Y Acad Sci 499, 104-123.
23. Awad AB, Bernardis LL & Fink CS (1990) Failure to demonstrate an effect of dietary fatty acid composition on body weight, body consumption and parameters of lipid metabolism in mature rats. J Nutr 120, 1277-1282.
24. Shimomura Y, Tamura T & Suzuki M (1990) Less body fat accumulation in rats fed a safflower oil diet than in rats fed a beef tallow diet. J Nutr 120, 1291-1296.
25. Hill JO, Peters JC, Lin D, et al. (1993) Lipid accumulation and body fat distribution is influenced by the type of dietary fed to rats. Int J Obes 17, 223-226.
26. Plutzky J (2000) Emerging concepts in metabolic abnormalities associated with coronary artery disease. Curr Opin Cardiol 15, 416-421.
27. Reaven GM (1988) Role of insulin resistance on human disease. Diabetes 37, 1595-1607.
28. Gordon ES, Glodberg M & Chosy GJ (1963) A new concept in the treatment of obesity. JAMA 186, 50-60.
29. Messerli FH, Christie B & De Carvalho JGR (1981) Obesity and essential hypertension: hemodynamics, intravascular volume, sodium excretion and plasma renin activity. Arch Intern Med 141, 81-85.
30. Rocchini AP, Katch V & Kvselis D (1989) Insulin and renal sodium retension in obese adolescents. Hypertension 14, 367-374.
31. Landberg L (1992) Hyperinslinemia: possible role in obesity-induced hypertension. Hypertension 19, Suppl. 1, 61-66.
32. Laragh JH (1985) Atrial natriuretic hormone, the reninealdosterone axis, and blood pressure-electrolyte homeostasis. N Engl J Med 313, 1330-1340.
33. De Pergola G, Garruti G, Giorgino F, et al. (1994) Reduced effectiveness of atrial natriuretic factor in pre-menopausal obese women. Int J Obes 18, 93-97.
34. Valensi P, Sibony-Prat J, Behar A, et al. (1997) Impairment of antidiuretic hormone and atrial natriuretic peptide regulation in the obese woman with a swelling syndrome and an increase in capillary permeability to albumin. Int J Obes 21, 651-657.
35. Oosterveer MH, van Dijk TH, Tietge UJF, et al. (2009) High fat feeding induces hepatic fatty acid elongation in mice. PLoS One 4, e6066.
36. Kanh BB & Flier JS (2000) Obesity and insulin resistance. J Clin Invest 106, 473-481.
37. Sumiyoshi M, Sakanaka M & Kimura Y (2006) Chronic intake of high-fat and high-sucrose diets differentially affects glucose intolerance in mice. J Nutr 136, 582-587.
38. Tontonoz P, Hu E & Spiegelman BM (1994) Stimulation of adipogenesis in fibroblast by PPAR gamma 2, a lipidactivated transcription factor. Cell 79, 1147-1156.
39. Evans M, Park Y, Pariza M, et al. (2001) Trans-10, cis-12 conjugated linoleic reduces triglyceride content while differentially affecting peroxisome proliferator activated receptor gamma2 and aP2 expression in 3T3-L1 preadipocytes. Lipids 36, 1223-1232.
40. Peterson KF, Krssak M, Inzucchi S, et al. (2000) Mechanism of troglitazone action in type 2, diabetes. Diabetes 49, 827-831.
41. Greene DA (1999) Rosiglitazone: a new therapy for type 2 diabetes. Exp Opin Invest Drug 8, 1709-1719.
42. Boden G, Homko C, Mozzoli M, et al. (2005) Thiazolidinediones upregulate fatty acid uptake and oxidation in adipose tissue of diabetic patients. Diabetes 54, 880-885.
43. Lee G, Elwood F, McNally J, et al. (2002) T007097, a selective ligand for peroxisome proliferator-activated receptor gamma, functions as an antagonist of biochemical and cellular activities. J Biol Chem 277, 19649-19657.